UCL Hospitals NHS Foundation Trust

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Head and neck cancer1 trial
• Lung cancer1 trial
• Osteoarthritis1 trial
• Ovarian cancer1 trial
• Pancreatic cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 1/21 trial

Status

• Recruiting2 trials

Lead sponsor

• Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.1 trial
• University College, London1 trial

Running trials

• Recruiting

  Mako Cementless TKA vs Mako Cemented TKA

  NCT06929871· University College, London· Source

  Contact: Jenni Tahmassebi, MSc

• Recruiting

  Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

  NCT05985655· Phase 1/2· Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.· Source

  Contact: Martin Forster (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Head and neck cancer1 recruiting
• Lung cancer1 recruiting
• Osteoarthritis1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Triple-negative breast cancer1 recruiting